reference/7957557

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7957557

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	3972
issn	1527-7755 0732-183X
issueIdentifier	25
pageRange	3965-3972
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	3965
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96
bibliographicCitation	Yap TA, Vidal L, Adam J, Stephens P, Spicer J, Shaw H, Ang J, Temple G, Bell S, Shahidi M, Uttenreuther-Fischer M, Stopfer P, Futreal A, Calvert H, de Bono JS, Plummer R. Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors. J Clin Oncol. 2010 Sep 01;28(25):3965–72. doi: 10.1200/jco.2009.26.7278. PMID: 20679611.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49d1030d8d2e7cf346258ed1dd4465dc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f421e4046f0337eb7c34a8d5b6888b09 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5dbc63234e5b77de0be4bd304187522e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0621173a7ff346cc2c70dbec7fb0a220 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e05032c6e60782959a4028df722c4391 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e1cdce104321a003ca1f52c627e9f5d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_786d3233da7d2259d314c5ece82b0200 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2af4c4cfcbc36b4acca4dd37d4e0a1e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74f687d583990dccae1b7374d90e383e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79fbef9c20dee04a927d2850a465df6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f59edb2cb163dd9421e309667e30de6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a02a7f283ca8c6cc87affb6005d04d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6acbb3838b3ef257f997a7de19367b06 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8c892dd32e281830b54c04e2275775e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04d4acdf3867fbb5d0ca1e5e7ccd712d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8515f2d100dc0eb5cb92bb0101b01589
date	2010-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2009.26.7278 https://pubmed.ncbi.nlm.nih.gov/20679611
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/1527-7755 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors
discusses	http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0500817 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0028048 http://id.nlm.nih.gov/mesh/M0561143 http://id.nlm.nih.gov/mesh/M0593322
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018719Q000037 http://id.nlm.nih.gov/mesh/D047428Q000008 http://id.nlm.nih.gov/mesh/D066246Q000037 http://id.nlm.nih.gov/mesh/D011799Q000008 http://id.nlm.nih.gov/mesh/D009369Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000077716 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D011799Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7521 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_45eac88548c6d302205578eef99eaf62 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7099 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7652 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10184653 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID178102295

Total number of triples: 74.